Poster 20: EVOLUTIONARY ASPECTS OF ACUTE MYELOID LEUKEMIA WITH AN
UNFAVORABLE GROUP.
Asmaa Harrach, Mouna Lamchahab, Siham Laajouri, Malak Lazizi, Nazha Hda,
Bouchra Oukkache and Asma Quessar
Poster 21: ACUTE MYELOID LEUKEMIA IN METHOTREXATE-TREATED CONNECTIVE
TISSUE DISEASE PATIENTS – A SECONDARY LEUKEMIA OR MERE
COINCIDENCE?
Joana Infante, Helena Martins, Sara Valle, João Forjaz Lacerda, Graça Esteves and João
Raposo
Poster 22: ACUTE PROMYELOCYTIC LEUKEMIA PRESENTING AS A MIDBRAIN STROKE
SYNDROME IN A YOUNG WOMAN
Joana Infante, Catarina Campos, Helena Martins, Daniela Alves, João Forjaz Lacerda,
Graça Esteves, Jose Ferro and João Raposo
Poster 23: TRAMETINIB THERAPY AND DISEASE MONITORING BY MUTATION SPECIFIC
DROPLET DIGITAL PCR IN RELAPSED PEDIATRIC ACUTE MYELOID LEUKEMIA:
A CASE REPORT
Szilvia Krizsán, Ambrus Gángó, Lajos Hegyi, Endre Sebestyén, Tibor Nagy, Dániel János
Erdélyi, Gergely Kriván, Krisztián Kállay, Gábor Kovács, Csaba Bödör and Donát Alpár
Poster 24: ACUTE MYELOID LEUKEMIA (AML) IN ELDERLY: EPIDEMIOLOGICAL, CLINICAL
AND BIOLOGICAL PROFILE OF PATIENTS AT HEMATOLOGY AND PEDIATRIC
ONCOLOGY DEPARTMENT IN CASABLANCA
Siham Laajouri, Mouna Lamchahab, Bouchra Oukkache and Asmaa Quessar
Poster 25: CYTOGENETIC ASPECTS OF ACUTE MYELOID LEUKEMIA: EXPERIENCE OF
HEMATOLOGY AND PEDIATRIC ONCOLOGY DEPARTMENT
Siham Laajouri, Mouna Lamchahab, Asmaa Harrach, Malak Lazizi, Bouchra Oukkache
and Asmaa Quessar
Poster 26: A CASE REPORT OF THE SECONDARY AML FOLLOWING ALLOGENIC STEM
CELL TRANSPLANTATION IN A 9 Y.O. PATIENT WITH THE FANCONI ANEMIA
Svetlana Lebedeva, Kristina Antonova, Natalya Timofeeva, Olga Soldatkina, Elena
Zerkalenkova, Yuliya Olshanskaya, Galina Novichkova, Michael Maschan, Irina Kalinina
and Aleksey Maschan
Poster 27: GILTERITINIB PROLONGS SURVIVAL IN PATIENTS WITH FLT3-MUTATED
RELAPSED/REFRACTORY AML WHO HAVE COMMON AML CO-MUTATIONS
OR A HIGH FLT3-ITD ALLELIC RATIO
Mark J. Levis, Alexander E. Perl, Giovanni Martinelli, Jorge E. Cortes, Andreas
Neubauer, Ellin Berman, Pau Montesinos, Maria R. Baer, Richard A. Larson, Wen-Chien
Chou, Hisayuki Yokoyama, Christian Recher, Sung-Soo Yoon, Jason E. Hill, Matt Rosales,
Chaofeng Liu and Erkut Bahceci
Poster 28: SAFETY, TOXICITY AND EFFICACY OF THE PEDIATRIC PROTOCOL BFM IN
ADOLESCENTS AND YOUNG PATIENTS WITH ACUTE LYMPHOBLASTIC
LEUKEMIA (ALL).
SCIENTIFIC
PROGRAMME
RARE SUBSETS OF
ACUTE LEUKAEMIA
TRACKING LEUKAEMIC
STEM CELLS (LSCs)
ROUTINE DIAGNOSIS
GENE EXPRESSION
AND MUTATIONAL
PROFILING
DEBATE 1 – ALL
PATIENTS WITH
INTERMEDIATE-RISK
AML MUST BE
TRANSPLANTED
INTERACTIVE
CASES 1 – MUTATION-BASED
THERAPY
OFF-LABEL
ROUNDTABLE –
SHOULD WE REALLY
USE NEW TARGETED
INHIBITORS AS SINGLE
AGENTS ?
ADDITION OF A 3RD
AGENT TO FRONTLINE
7+3
ROUNDTABLE –
CURATIVE OPTIONS
FOR OLDER AML
INTERACTIVE CASES 2
DEBATE 2 - BEST
TREATMENT FOR
NPM1-MUTATED AML IN
THE NEXT FUTURE ?
ALLOGENEIC
HAEMATOPOIETIC
STEM CELL
TRANSPLANTATION
(HSCT)
IMMUNOTHERAPY FOR
ACUTE LEUKAEMIA
DEBATE 3 - T-ALL:
WHERE ARE WE GOING
NOW?
SELECTED ABSTRACTS
AND CLINICAL
CASES FOR AN ORAL
PRESENTATION
SELECTED ABSTRACTS
FOR A POSTER
PRESENTATION
DISCLOSURES